✦ LIBER ✦

Vasopressin V2 Receptor Blockade With Tolvaptan Versus Fluid Restriction in the Treatment of Hyponatremia

✍ Scribed by Mihai Gheorghiade; Stephen S. Gottlieb; James E. Udelson; Marvin A. Konstam; Frank Czerwiec; John Ouyang; Cesare Orlandi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyponatremia in Cirrhosis and End-Stage

✍ Paul Gaglio, Kwaku Marfo, Joseph Chiodo III 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 449 KB

Effects of the Vasopressin V2 Receptor A

✍ James E. Udelson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Conivaptan, a Vasopressin-Receptor Antag

✍ Jalal K. Ghali; Bo Yan; Bruce McNutt 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Acute Hemodynamic Effects of Tolvaptan,

✍ James E. Udelson; Cesare Orlandi; John Ouyang; Holly Krasa; Christopher A. Zimme 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 96 KB